|
"shao yu yun"的相关文件
显示项目 1-25 / 94 (共4页)
1 2 3 4 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-05-12T07:37:59Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
Shao, Yu-Yun; Chen, Pai-Sheng; LIANG-IN LIN; Lee, Bin-Shyun; Ling, Andrew; Cheng, Ann-Lii; CHIUN HSU; Ou, Da-Liang |
| 臺大學術典藏 |
2022-05-12T02:20:13Z |
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
|
Chen, Ching-Tso; Liu, Tsung-Hao; Shao, Yu-Yun; KAO-LANG LIU; Liang, Po-Chin; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2022-04-14T07:44:52Z |
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
|
Shao, Yu-Yun; Kuo, Hung-Yang; Jeng, Yung-Ming; YAO-MING WU; Wang, Hsiu-Po; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey-Chi; Cheng, Ann-Lii; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2022-02-16T03:00:55Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao, Yu-Yun; Wang, Shen-Yung; Lin, Shi-Ming; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; JA-DER LIANG |
| 臺大學術典藏 |
2022-01-14T03:38:07Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin, Zhong-Zhe; Chen, Bang-Bin; Hung, Yi-Ping; HUANG, PO-HSIANG; Shen, Ying-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; Lee, Rheun-Chuan; Chao, Yee; Chiun Hsu |
| 臺大學術典藏 |
2021-12-16T03:39:19Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-16T03:25:51Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
Chen, Bang-Bin; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-16T02:10:26Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
BANG-BIN CHEN; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-16T02:03:28Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
BANG-BIN CHEN; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-15T07:39:40Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-15T07:29:31Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
Chen, Bang-Bin; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-15T07:27:12Z |
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
|
Chen, Ching-Tso; Liu, Tsung-Hao; Shao, Yu-Yun; Liu, Kao-Lang; PO-CHIN LIANG; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2021-11-24T08:20:52Z |
Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma
|
Shao, Yu-Yun; Sun, Nai-Yun; Jeng, Yung-Ming; YAO-MING WU; CHIUN HSU; Hsu, Chih-Hung; Hsu, Hey-Chi; Cheng, Ann-Lii; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2021-03-22T07:10:10Z |
Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
|
Wu, Chih-Horng; Liang, Po-Chin; Hsu, Chih-Hung; Chang, Fang-Tsu; Shao, Yu-Yun; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-03-22T07:08:54Z |
Reply to letter to the editor: Low skeletal muscle mass are predictive factors of survival for advanced hepatocellular carcinoma
|
Wu, Chih-Horng; Shao, Yu-Yun; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-03-22T03:14:34Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao, Yu-Yun; Wang, Shen-Yung; Lin, Shi-Ming; PO-CHIN LIANG |
| 臺大學術典藏 |
2021-03-22T02:56:54Z |
Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma
|
CHIH-HORNG WU; Liang, Po-Chin; Hsu, Chih-Hung; Chang, Fang-Tsu; Shao, Yu-Yun; Ting-Fang Shih, Tiffany |
| 臺大學術典藏 |
2020-04-09T09:43:48Z |
Right or left? Side selection for a totally implantable vascular access device: A randomised observational study
|
Lin, Wen Ying; Lin, Chih Peng; Hsu, Chih Hung; Lee, Ying Hui; Lin, Yi Ting; Hsu, Meng Chi; Shao, Yu Yun |
| 臺大學術典藏 |
2020-04-09T09:40:33Z |
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life
|
Chou, Wen Chi; Hsieh, Ruey Kuen;Chang, Cheng Shyong;Lai, Pang Yu;Hwang, Wen Li;Yu, Ming Sun;Lee, Ming Yang;Wu, Ming Fang;Liu, Ta Chih;Yeh, Su Peng;Yen, Chia Jui;Rau, Kun Ming;Sung, Yung Chuan;Chiou, Tzeon Jye;Shao, Yu Yun;Lu, Chang Hsien;Hung, Chia Yen;Chen, Jen Shi;Chou, Wen Chi; Chen, Jen Shi; Hung, Chia Yen; Lu, Chang Hsien; Shao, Yu Yun; Chiou, Tzeon Jye; Sung, Yung Chuan; Rau, Kun Ming; Yen, Chia Jui; Yeh, Su Peng; Liu, Ta Chih; Wu, Ming Fang; Lee, Ming Yang; Yu, Ming Sun; Hwang, Wen Li; Lai, Pang Yu; Chang, Cheng Shyong; Hsieh, Ruey Kuen |
| 臺大學術典藏 |
2020-04-09T09:38:50Z |
Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma
|
Shao, Yu-Yun; Liu, Tsung-Hao; Lee, Ying-Hui; Hsu, Chih-Hung; Cheng, Ann-Lii |
| 臺大學術典藏 |
2020-04-09T09:37:27Z |
Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management
|
Hadjiat, Yacine;Colin, Consuelo Gutierrez;Buemio, Kristal Cielo;Yaakup, Hayati;Shao, Yu Yun;Salti, Amar;Palladini, Mariana;Olarte, Gabriel;Lu, Henry;Le, Brian;Chye, Richard;Ahn, Jin Seok;O'Brien, Tony; O'Brien, Tony; Ahn, Jin Seok; Chye, Richard; Le, Brian; Lu, Henry; Olarte, Gabriel; Palladini, Mariana; Salti, Amar; Shao, Yu Yun; Yaakup, Hayati; Buemio, Kristal Cielo; Colin, Consuelo Gutierrez; Hadjiat, Yacine |
| 臺大學術典藏 |
2020-04-09T09:36:48Z |
Cyclin E1 Inhibition can Overcome Sorafenib Resistance in Hepatocellular Carcinoma Cells Through Mcl-1 Suppression
|
Hsu, Chiun; Lin, Liang-In; Cheng, Yu-Che; Feng, Zi-Rui; Shao, Yu-Yun; Cheng, Ann-Lii; Ou, Da-Liang |
| 臺大學術典藏 |
2020-04-09T09:35:07Z |
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study
|
Cho, Shih Feng; Rau, Kun Ming; Shao, Yu Yun; Yen, Chia Jui; Wu, Ming Fang; Chen, Jen Shi; Chang, Cheng Shyong; Yeh, Su Peng; Chiou, Tzeon Jye; Hsieh, Ruey Kuen; Lee, Ming Yang; Sung, Yung Chuan; Lee, Kuan Der; Lai, Pang Yu; Yu, Ming Sun; Hwang, Wen Li; Liu, Ta Chih; Liu, Ta Chih;Hwang, Wen Li;Yu, Ming Sun;Lai, Pang Yu;Lee, Kuan Der;Sung, Yung Chuan;Lee, Ming Yang;Hsieh, Ruey Kuen;Chiou, Tzeon Jye;Yeh, Su Peng;Chang, Cheng Shyong;Chen, Jen Shi;Wu, Ming Fang;Yen, Chia Jui;Shao, Yu Yun;Rau, Kun Ming;Cho, Shih Feng |
| 臺大學術典藏 |
2020-04-09T09:34:35Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
Cheng, Ann Lii;Hsu, Chih Hung;Lin, Zhong Zhe;Hsu, Chiun;Shen, Ying Chun;Lu, Li Chun;Shao, Yu Yun;Liu, Tsung Hao; Liu, Tsung Hao; Shao, Yu Yun; Lu, Li Chun; Shen, Ying Chun; Hsu, Chiun; Lin, Zhong Zhe; Hsu, Chih Hung; Cheng, Ann Lii |
| 臺大學術典藏 |
2020-04-09T09:33:46Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Hsu, Chih Hung;Huang, Ta Chen;Shao, Yu Yun;Lien, Ming Yu;Kuo, Hung Yang;Hsieh, Min Shu;Lin, Chen Yuan;Lin, Chia Chi;Guo, Jhe Cyuan; Guo, Jhe Cyuan; Lin, Chia Chi; Lin, Chen Yuan; Hsieh, Min Shu; Kuo, Hung Yang; Lien, Ming Yu; Shao, Yu Yun; Huang, Ta Chen; Hsu, Chih Hung |
显示项目 1-25 / 94 (共4页)
1 2 3 4 > >>
每页显示[10|25|50]项目
|
